Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 701–800 of 1,014
Spinal Cord Injury and Bladder Dysfunction: New Ideas about an Old Problem
Cruz, C. D., & Cruz, F. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.26 · Cited by 68
“As for CPGs, it has been shown that interference with the glycosylmoiety of these glycoproteins using chondroitinasemay lead to improved regrowth of spared neuronal processes as well as stimulation of functional recovery[210,211,212,213].”
BackgroundWang, X., Hasan, O., Arzeno, A., Benowitz, L. I., Cafferty, W. B. J., & Strittmatter, S. M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.009 · Cited by 67
Jun-mei, W., Zeng, Y., Wu, J., Li, Y., & Teng, Y. D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.036 · Cited by 68
Lorpitthaya, R., Xie, Z., Kuo, J., & Liu, X. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200701288 · Cited by 68
Izumikawa, T., Kitagawa, H., Mizuguchi, S., Nomura, K. H., Nomura, K., Tamura, J.-I., Gengyo‐Ando, K., Mitani, S., & Sugahara, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409615200 · Cited by 68
Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase
Moon, L. D. F., Asher, R. A., & Fawcett, J. W. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10449 · Cited by 68
“…et al., 1997; Fidler et al., 1999; Niederöst et al., 1999), disrupts axon guidance in the embryo (Chung et al., 2000), enhances growth of CNS neurons into peripheral nerve implants (Yick et al., 2000) and enhances regeneration of cut CNS axons in vivo (Moon et al., 2001; Bradbury et al., 2002).”
BackgroundSelf-citationMa, W., Zhan, Y., Zhang, Y., Xie, X., Mao, C., & Lin, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b19079 · Cited by 67
Chio, J. C. T., Punjani, N., Hejrati, N., Zavvarian, M.-M., Hong, J., & Fehlings, M. G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0120 · Cited by 69
Astrocytes in functional recovery following central nervous system injuries
Alhadidi, Q., Bahader, G. A., Arvola, O., Kitchen, P., Shah, Z. A., & Salman, M. M. (2023) · The Journal of Physiology · doi:10.1113/jp284197 · Cited by 75
Haupt, L., Murali, S., Mun, F. K., Teplyuk, N., Mei, L. F., Stein, G., VanWijnen, A., Nurcombe, V., & Cool, S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21825 · Cited by 64
“…E O G L Y C A N G E N E S 787 importance of GAGs for the regulation of many physiological processes including morphogenesis and development, viral invasion, cancer metastasis, and spinal cord injury (Bradbury et al., 2002; Capila and Linhardt, 2002; Sasisekharan et al., 2002; Hacker et al., 2005).”
BackgroundGuley, N., Rogers, J. T., Mar, N. A. D., Deng, Y., Islam, R. M., D’Surney, L., Ferrell, J. M., Deng, B., Hines-Beard, J., Bu, W., et al. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.3886 · Cited by 71
Soleman, S., Yip, P. K., Leasure, J. L., & Moon, L. D. F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.007 · Cited by 79
“The extent of injury was also determined at spinal level using immunostaining for protein kinase C γ (PKCγ) to determine whether the ET-1 induced lesion led to a loss of corticospinal tract (CST) axons within the cervical spinal cord (Barritt et al., 2006; Bradbury et al., 2002; Starkey et al., 2005).”
Self-citationChen, J., Cheng, G., Sheu, C., Tseng, G., Wang, T., & Huang, Y. (2008) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.00948.x · Cited by 67
“The tape removal test (Bradbury et al. 2002; Sughrue et al. 2006) produced separate scores for sensory and motor behavior.”
BackgroundSialidase enhances recovery from spinal cord contusion injury
Mountney, A., Zahner, M. R., Lorenzini, I., Oudega, M., Schramm, L. P., & Schnaar, R. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006683107 · Cited by 69
“One such treatment, delivery of the bacterial enzyme chondroitinase ABC to remove chondroitin sulfate chains from proteoglycans in the injured spinal cord, shows promise in preclinical trials (10, 11).”
BackgroundNG2/CSPG4 and progranulin in the posttraumatic glial scar
Schäfer, M. K. E., & Tegeder, I. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.10.002 · Cited by 72
Li, X., & Dai, J. (2017) · Biomaterials Science · doi:10.1039/c7bm00974g · Cited by 69
Bao, X., Muramatsu, T., & Sugahara, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507304200 · Cited by 75
Chronic spinal cord injury repair by NT3-chitosan only occurs after clearance of the lesion scar
Zhao, C., Rao, J., Duan, H., Hao, P., Shang, J., Fan, Y., Zhao, W., Gao, Y., Yang, Z., Sun, Y. E., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01010-1 · Cited by 68
“Failure of nerve regeneration in the central nervous system (CNS) root from attenuated axonal growth potential, which is intrinsic to CNS neurons, as well as inhibitory CNS injury environment, which is filled with myelin debris, inflammatory cytokines, and cells producing inhibitory molecules, all are detrimental to s…”
BackgroundAyazi, M., Zivkovic, S., Hammel, G., Stefanovic, B., & Ren, Y. (2022) · Cells · doi:10.3390/cells11152371 · Cited by 71
Insights into the physiological role of CNS regeneration inhibitors
Baldwin, K. T., & Giger, R. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00023 · Cited by 69
“CSPGs are secreted by astrocytes, neurons, and oligodendrocytes (Ogawa et al., 2001), and they are strongly enriched at the glial scar after CNS injury where they inhibit regenerative growth and restrict plasticity (Bradbury et al., 2002; Morgenstern et al., 2002; Silver and Miller, 2004).”
Exploring Optic Nerve Axon Regeneration
Li, H., Sun, Z.-L., Yang, X., Zhu, L., & Feng, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161227150250 · Cited by 70
“After ON injury, CSPGs, which are secreted by astrocytes, neurons and oligodendrocytes, are strongly enriched at the glial scar, where they inhibit axon regenerative growth and restrict plasticity [83, 93, 94].”
BackgroundPotent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro
Vyas, A. A., Blixt, O., Paulson, J. C., & Schnaar, R. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500250200 · Cited by 66
Molecular targets in spinal cord injury
Klußmann, S., & Martín-Villalba, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0663-3 · Cited by 72
“Along this line, the enzymatic digestion of CSPGs by chondroitinase ABC allowed some lesioned axons to regenerate across the scar tissue [108].”
BackgroundReparative mechanisms in the cerebellar cortex
Carulli, D., Buffo, A., & Strata, P. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.007 · Cited by 68
The role of neural stem cells in regulating glial scar formation and repair
Nicaise, A. M., D’Angelo, A., Ionescu, R.-B., Krzak, G., Willis, C. M., & Pluchino, S. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03554-0 · Cited by 65
“Moreover, several other ECM proteins have been reported to inhibit axonal regeneration such as chondroitin sulfate glycosaminoglycans (Bradbury et al. 2002) and tenascin proteins (Roll and Faissner 2019).”
BackgroundPluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
Singh, R. K., Cuzzani, O., Binette, F., Sternberg, H., West, M. D., & Nasonkin, I. O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9802-4 · Cited by 69
“Localized degradation of CSP with bacterial enzyme chondroitinase ABC promotes functional recovery after spinal cord damage [237, 238] as well as migration and integration of transplanted retinal cells in subretinal space [239, 240].”
Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons
Minor, K. H., Tang, X., Kahrilas, G. A., Archibald, S. J., Davies, J. E., & Davies, S. J. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.009 · Cited by 77
Integrin signaling is integral to regeneration
Lemons, M. L., & Condic, M. L. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.027 · Cited by 65
Harris, N. G., Carmichael, S. T., Hovda, D. A., & Sutton, R. L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22115 · Cited by 62
“By using this CSPG ablation technique, improvements in axonal sprouting and functional outcome have been measured (Moon et al., 2001a; Bradbury et al., 2002; Pizzorusso et al., 2002; Tropea et al., 2003; Yick et al., 2003).”
BackgroundMethodTom, V. J., Sandrow-Feinberg, H. R., Miller, K., Domitrovich, C., Bouyer, J., Zhukareva, V. A., Klaw, M. C., Lemay, M. A., & Houlé, J. D. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.011 · Cited by 71
“…ABC (ChABC), which cleaves the inhibitory sugar moiety from CSPG, is applied to a spinal cord injury site, axons are better able to regenerate and/or sprout beyond the normally inhibitory interface (Alilain et al., 2011; Barritt et al., 2006; Bradbury et al., 2002; Tom et al., 2009a).”
GDNF selectively promotes regeneration of injury-primed sensory neurons in the lesioned spinal cord
Mills, C. D., Allchorne, A. J., Griffin, R. S., Woolf, C. J., & Costigan, M. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.06.011 · Cited by 70
“…(Schnell and Schwab, 1990,Bartsch, 1996,Wang et al., 2002) and degrading the inhibitory glycoprotein matrix in the CNS with chondroitinase (Bradbury et al., 2002,Massey et al., 2006,Massey et al., 2007), as well as providing permissive substrates for growth (Ramon-Cueto and Santos-Benito,…”
BackgroundA Novel Eliminase from a Marine Bacterium That Degrades Hyaluronan and Chondroitin Sulfate
Han, W., Wang, W., Zhao, M. Y., Sugahara, K., & Li, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590752 · Cited by 68
“CS/DS lyases are not only useful tools for investigating the structure-function relationship and the preparation of bioactive oligosaccharides of CS/DS but are also potential therapeutic agents for the treatment of injuries to the central nervous system (29).”
BackgroundDePaul, M. A., Palmer, M., Lang, B. T., Cutrone, R., Tran, A. P., Madalena, K. M., Bogaerts, A., Hamilton, J. A., Deans, R., Mays, R. W., et al. (2015) · Scientific Reports · doi:10.1038/srep16795 · Cited by 67
Hettiaratchi, M. H., O’Meara, M. J., Teal, C. J., Payne, S. L., Pickering, A. J., & Shoichet, M. S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.033 · Cited by 67
Deepa, S. S., Yamada, S., Fukui, S., & Sugahara, K. (2007) · Glycobiology · doi:10.1093/glycob/cwm021 · Cited by 66
Harris, J. P., Struzyna, L. A., Murphy, P. L., Adewole, D. O., Kuo, E., & Cullen, D. K. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/1/016019 · Cited by 71
Pizzolato, C., Gunduz, M. A., Palipana, D. B., Wu, J., Grant, G. D., Hall, S., Dennison, R., ZAFONTE, R. D., Lloyd, D. G., & Teng, Y. D. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113612 · Cited by 72
Remyelination Therapy for Multiple Sclerosis
Keough, M. B., & Yong, V. W. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0152-7 · Cited by 74
“Because it is known that CSPGs also inhibit axonal regeneration, and perturbation of CSPGs promotes axonal sprouting [128, 129], it could be argued that increased remyelination after xyloside treatment is a consequence of increased axonal targets for new sheath development and not per se true remyelination.”
BackgroundIseda, T., Okuda, T., Kane‐Goldsmith, N., Mathew, M., Ahmed, S., Chang, Y.-W., Young, W., & Grumet, M. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0289 · Cited by 71
“Other investigators have reported that non-contusive spinal cord injuries resulted in accumulation of CSPGs sufficient to inhibit axonal growth and chondroitinase treatment reduced the inhibition (Bradbury et al., 2002; Davies et al., 1996; Yick et al., 2003).”
InfluentialOmoto, S., Ueno, M., Mochio, S., Takai, T., & Yamashita, T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3228-10.2010 · Cited by 72
“We first examined PirB expression in corticospinal and rubrospinal neu- cervical spinal cord was stained with PKC , a marker of the CST, at 1 week after the injury (Bradbury et al., 2002).”
MethodChondroitin Sulfate/Dermatan Sulfate Hybrid Chains in the Development of Cerebellum
Mitsunaga, C., Mikami, T., Mizumoto, S., Fukuda, J., & Sugahara, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510870200 · Cited by 62
Proteoglycans and injury of the central nervous system
Matsui, F., & Oohira, A. (2004) · Congenital Anomalies · doi:10.1111/j.1741-4520.2004.00038.x · Cited by 64
“In a spinal cord injury, injection of chondroitinase ABC not only promoted axonal regeneration but also improved functions, such as postsynaptic activity and locomotion (Bradbury et al. 2002).”
BackgroundMotor Recovery and Anatomical Evidence of Axonal Regrowth in Spinal Cord-Repaired Adult Rats
Lee, Y., Lin, C., Robertson, R. T., Hsiao, I. N., & Lin, V. W.-H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.3.223-a · Cited by 63
“Using chondroitinase treatment to minimize the scar formation has been demonstrated to facilitate axonal regeneration after spinal cord injury (25).”
BackgroundTenascins and inflammation in disorders of the nervous system
Jakovčevski, I., Miljković, D. M., Schachner, M., & Anđjus, P. R. (2012) · Amino Acids · doi:10.1007/s00726-012-1446-0 · Cited by 69
“Improved recovery from spinal cord injury after application of chondroitinase ABC (Bradbury et al., 2002) is possibly also attributable to enzymatic degradation of the perineuronal nets and concomitant removal of growth-inhibiting chondroitin sulfate proteoglycans (Rhodes and Fawcett, 2004).”
Chondroitin sulphate-based 3D scaffolds containing MWCNTs for nervous tissue repair
Serrano, M. C., Nardecchia, S., García‐Rama, C., Ferrer, M. L., Collazos-Castro, J. E., del Monte, F., & Gutiérrez, M. C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.017 · Cited by 66
Peterson, S. L., & Anderson, A. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.028 · Cited by 75
“For example, the glial scar is formed from migrating astrocytes and other cells, and is known to act as a physical and chemical barrier to axon regeneration (Bradbury et al., 2002; Fawcett and Asher, 1999).”
BackgroundAxon plasticity in the mammalian central nervous system after injury
Chen, M., & Zheng, B. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.008 · Cited by 65
Surgical Neurostimulation for Spinal Cord Injury
Chari, A., Hentall, I. D., Papadopoulos, M. C., & Pereira, E. A. C. (2017) · Brain Sciences · doi:10.3390/brainsci7020018 · Cited by 64
“A number of promising restorative and regenerative therapies, including the delivery of olfactory ensheathing cells to act as a scaffold [28,29], chondroitinase therapy to limit the glial scar [30] and taxol therapy to promote microtubule stabilization [31], have sought to target these mechanisms, with limited clinica…”
BackgroundChondroitin Sulfate Impairs Neural Stem Cell Migration Through ROCK Activation
Galindo, L. T., Mundim, M. V., Pinto, A. A. S., Chiarantin, G. M. D., de Almeida, M. E. S., Lamers, M. L., Horwitz, A. R., dos Santos, M. F., & Porcionatto, M. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0565-8 · Cited by 63
“inhibition and RhoA activation [8, 19, 22], we hypothesized that a similar mechanism may occur during neural stem cell adhesion and migration.”
Brennan, F. H., & Popovich, P. G. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000550 · Cited by 67
“These events collectively improve vascularity, neuronal survival, functional recovery, regeneration, axonal conduction and motor recovery in preclinical SCI [65,66].”
BackgroundLynskey, J. V., Sandhu, F. A., Dai, H., McAtee, M., Slotkin, J. R., MacArthur, L. H., & Bregman, B. S. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.617 · Cited by 63
“…and Schwab, 1990; Bregman et al., 1995; Guest et al., 1997; von Meyenburg et al., 1998; Brosamle et al., 2000), neuroprotection (Pencalet et al., 1993; Gaviria et al., 2000) and the degradation of proteoglycans (Zuo et al., 1998; Bradbury et al., 2002; Grimpe and Silver, 2004; Fouad et al., 2005).”
Gopalakrishnan, S. M., Teusch, N., Imhof, C., Bakker, M. H. M., Schurdak, M., Burns, D. J., & Warrior, U. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21671 · Cited by 62
“DOI: 10.1002/jnr.21671 ' 2008 Wiley-Liss, Inc. the inhibitory effect of CSPGs such as digestion by chondroitinase and enzymatic suppression of glycosaminoglycan synthesis were partially successful in increasing axonal sprouting (Bradbury et al., 2002).”
BackgroundInfluentialWu, D., Klaw, M. C., Connors, T. M., Kholodilov, N. G., Burke, R. E., & Tom, V. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-15.2015 · Cited by 64
Kim, B. G., Dai, H., Lynskey, J. V., McAtee, M., & Bregman, B. S. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20980 · Cited by 67
Huang, C., Sakry, D., Menzel, L., Dangel, L., Sebastiani, A., Krämer, T. J., Karram, K., Engelhard, K., Trotter, J., & Schäfer, M. K. E. (2015) · Glia · doi:10.1002/glia.22944 · Cited by 65
“OPC proliferation has been further demonstrated in response to SCI (McTigue et al., 2001) and laser-induced cortical lesions (Hughes et al., 2013).”
BackgroundInfluentialClinical translation of stem cell based interventions for spinal cord injury — Are we there yet?
Chhabra, H. S., & Sarda, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.021 · Cited by 62
Beggah, A., Dours-Zimmermann, M. T., Barras, F. M., Brosius, A., Zimmermann, D., & Zurn, A. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.005 · Cited by 67
Astrocytes as support for axonal regeneration in the central nervous system of mammals
Privat, A. (2003) · Glia · doi:10.1002/glia.10249 · Cited by 62
“In most recent approaches, such as our work and that of Schwab (2002) and Bradbury et al. (2002), experimental demonstration of axonal regeneration after a lesion is not readily applicable to human pathology.”
BackgroundApplications of induced pluripotent stem cell technologies in spinal cord injury
Nagoshi, N., & Okano, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13986 · Cited by 63
Cooke, P., Janowitz, H. N., & Dougherty, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.872501 · Cited by 68
“Previous studies had recorded motor recovery following incomplete spinal cord injuries, in which only half the spine is damaged, using behavioral tests or extracellular recordings in the spinal cord following stimulation in the motor cortex (Bregman et al., 1995; Bradbury et al., 2002).”
BackgroundResultCan cell therapy heal a spinal cord injury?
Ronsyn, M. W., Berneman, Z. N., Tendeloo, V. F. V., Jorens, P. G., & Ponsaerts, P. (2008) · Spinal Cord · doi:10.1038/sc.2008.13 · Cited by 67
Harris, N. G., Mironova, Y. A., Hovda, D. A., & Sutton, R. L. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1470 · Cited by 71
“…promote axon sprouting, based on the idea that improving brain circuitry, either by enhanced sprouting of existing circuits or by the creation of new pathways around the injury site, will improve function after debilitating injury (Bradbury et al., 2002; Seymour et al., 2005; Smith et al., 2007).”
InfluentialVisual Cortex Plasticity: A Complex Interplay of Genetic and Environmental Influences
Maya‐Vetencourt, J. F., & Origlia, N. (2012) · Neural Plasticity · doi:10.1155/2012/631965 · Cited by 72
“This is consistent with the notion that removing extracellular matrix components that are inhibitory for axonal growth [65, 66] provides a permissive environment for structural plasticity (e.”
BackgroundPetrosyan, H. A., Hunanyan, A. S., Alessi, V., Schnell, L., Levine, J. M., & Arvanian, V. L. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4702-12.2013 · Cited by 67
“Digestion of CSPGs with the bacterial enzyme chondroitinase-ABC (Ch-ABC) (Yamagata et al., 1968) enhances axonal sprouting and regeneration in the damaged CNS (Moon et al., 2001; Bradbury et al., 2002; Caggiano et al., 2005; Tom et al., 2009; Alilain et al., 2011; García-Alías et al., 2011).”
BackgroundInfluentialEvolution of tibial SSEP after traumatic spinal cord injury: Baseline for clinical trials
Spiess, M. R., Schubert, M. J. W., Kliesch, U., & Halder, P. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.01.021 · Cited by 61
“Recent progress in the field of spinal cord repair in animals shows the potential to significantly improve the functional outcome after human spinal cord injury (e.g. Bradbury et al., 2002; Buchli and Schwab, 2005; Schwab, 2002; Wong et al., 2006; Zhang et al., 2007).”
BackgroundClinical and Experimental Advances in Regeneration of Spinal Cord Injury
Hyun, J. K., & Kim, H. (2010) · Journal of Tissue Engineering · doi:10.4061/2010/650857 · Cited by 65
“Chondroitinase ABC (chABC), which digests CSPG, was administered intrathecally into injured spinal cord in rats, and this treatment upregulated regeneration-associated protein, restored electrophysiological activities, and promoted functional recovery [113].”
BackgroundYang, E., Zhang, G., Xu, J., Chen, S., Wang, H., Cao, L., Liang, B., & Lian, X. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.11 · Cited by 62
Determinants of Axon Growth, Plasticity, and Regeneration in the Context of Spinal Cord Injury
Filous, A. R., & Schwab, J. M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.09.005 · Cited by 67
“Major progress has been made in understanding what impedes regeneration after SCI.”
BackgroundInfluentialDyck, S. M., Kataria, H., Akbari‐Kelachayeh, K., Silver, J., & Karimi‐Abdolrezaee, S. (2018) · Glia · doi:10.1002/glia.23533 · Cited by 61
“CSPGs are shown to negatively influence several aspects of the secondary injury mechanisms including neuroinflammation, cell differentiation as well as axonal plasticity and regeneration (Alilain, Horn, Hu, Dick, & Silver, 2011; Barritt et al., 2006; Bradbury et al., 2002; Didangelos, Iberl, Vinsland, Bartus, & Bradbu…”
BackgroundProteoglycans as Modulators of Axon Guidance Cue Function
de Wit, J., & Verhaagen, J. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-70956-7_7 · Cited by 61
Reversible age impairments in neurite outgrowth by manipulations of astrocytic GFAP
Rozovsky, I., Wei, M., Morgan, T. E., & Finch, C. E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.009 · Cited by 63
Wilcox, J. T., Satkunendrarajah, K., Zuccato, J., Nassiri, F., & Fehlings, M. G. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0029 · Cited by 65
Chan, C. C. M., Wong, A. K., Liu, J., Steeves, J. D., & Tetzlaff, W. (2007) · Glia · doi:10.1002/glia.20466 · Cited by 58
“Failure of axonal regeneration in the spinal cord results in part from an upregulation of CSPGs surrounding the lesion (Bradbury et al., 2002; Davies et al., 1999).”
BackgroundJanzadeh, A., Sarveazad, A., Yousefifard, M., Dameni, S., Samani, F. S., Mokhtarian, K., & Nasirinezhad, F. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.06.002 · Cited by 60
“The second selected treatment was administration of ChABC enzyme which plays a direct role in destruction of the barrier through decomposition of CSPG and creates a permeable environment for axon regeneration (Bradbury et al., 2002; Lee et al., 2010).”
Bouslama-Oueghlani, L., Wehrlé, R., Sotelo, C., & Dusart, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08318.2003 · Cited by 58
“Furthermore, reactive astrocytes are able to produce proteoglycan molecules that are known to be inhibitors for regeneration (McKeon et al., 1991; Moon et al., 2001; Bradbury et al., 2002).”
BackgroundHaylock‐Jacobs, S., Keough, M. B., Lau, L. W., & Yong, V. W. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.019 · Cited by 63
Nothias, J. M., Mitsui, T., Shumsky, J. S., Fischer, I., Antonacci, M. D., & Murray, M. (2005) · Neurorehabilitation and neural repair · doi:10.1177/1545968305281209 · Cited by 60
Two PTP receptors mediate CSPG inhibition by convergent and divergent signaling pathways in neurons
Ohtake, Y., Wong, D., Abdul-Muneer, P. M., Selzer, M. E., & Li, S. (2016) · Scientific Reports · doi:10.1038/srep37152 · Cited by 59
Dynamic role of kallikrein 6 in traumatic spinal cord injury
Scarisbrick, I. A., Sabharwal, P., Cruz, H., Larsen, N. J., Vandell, A. G., Blaber, S. I., Ameenuddin, S., Papke, L. M., Fehlings, M. G., Reeves, R. K., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05021.x · Cited by 62
“, 2003) such that their digestion by chondroitinase promotes axonal regeneration in rodent models of spinal cord injury (Zuo et al., 1998b; Moon et al., 2001; Bradbury et al., 2002).”
BackgroundExtracellular matrix remodeling during retinal development
Reinhard, J., Joachim, S. C., & Faissner, A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.07.001 · Cited by 63
Nomura, H., Baladie, B., Katayama, Y., Morshead, C. M., Shoichet, M. S., & Tator, C. H. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316443.88403.16 · Cited by 59
Quintá, H. R., Pasquini, J. M., Rabinovich, G. A., & Pasquini, L. A. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.14 · Cited by 63
Radulovic, M., Yoon, H., Wu, J., Mustafa, K., & Scarisbrick, I. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.010 · Cited by 61
“evaluated using an antibody recognizing the gamma subunit of protein kinase C (PKCγ sc-211 Santa Cruz, Dallas, TX) (Bradbury et al., 2002; Lieu et al., 2013).”
InfluentialExtracellular matrix in the CNS: Dynamic structure and clinical correlations
Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000002044 · Cited by 63
“The most commonly utilized approach to promote clearance of inhibitory CSPGs is the removal of their GAG chains using bacterial chondroitinase ABC in order to promote axonal growth; its potential beneficial effect was first demonstrated in experimental models of SCI.(74) Approaches to reduce production of ECM componen…”
Role of Chondroitin Sulfation Following Spinal Cord Injury
Hussein, R. K., Mencio, C. P., Katagiri, Y., Brake, A., & Geller, H. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00208 · Cited by 61
The Molecular Basis of Neural Regeneration
Jacobs, W. B., & Fehlings, M. G. (2003) · Neurosurgery · doi:10.1227/01.neu.0000083592.74383.b1 · Cited by 59
Usher, L., Johnstone, A. L., Ertürk, A., Hu, Y. J., Strikis, D., Wanner, I. B., Moorman, S., Lee, J.-W., Min, J., Ha, H., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0302-10.2010 · Cited by 60
“, 1999; Fawcett and Asher, 1999; Silver and Miller, 2004), and a major group of inhibitory proteins in the glial scar comprises the CSPGs (McKeon et al., 1995; Bradbury et al., 2002; Davies et al., 2004; Grimpe and Silver, 2004).”
BackgroundA Semaphorin 3A Inhibitor Blocks Axonal Chemorepulsion and Enhances Axon Regeneration
Montolio, M., Messeguer, J., Masip, I., Guijarro, P., Gavín, R., del Río, J. A., Messeguer, Á., & Soriano, E. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.006 · Cited by 62
Roloff, F., Scheiblich, H., Dewitz, C., Dempewolf, S., Stern, M. K., & Bicker, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118536 · Cited by 58
“proteoglycans (CSPGs) forming scar tissue [2,3] and myelin-producing oligodendrocytes that expose myelin associated glycoprotein (MAG), Nogo-A [4] and oligodendrocyte myelin glycoprotein (OMgp) as growth-inhibitory factors [5–8] to the axons.”
BackgroundDevaux, S., Čížková, D., Quanico, J. P., Franck, J., Nataf, S., Pays, L., Hauberg‐Lotte, L., Maaß, P., Kobarg, J. H., Kobeissy, F. H., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057794 · Cited by 63
“hibit the regeneration of damaged axons (11).”
Therapeutic Stimulation for Restoration of Function After Spinal Cord Injury
Ievins, A., & Moritz, C. T. (2017) · Physiology · doi:10.1152/physiol.00010.2017 · Cited by 61
“Similarly, dissolution of chondroitin sulfate proteoglycans (CSPGs), extracellular matrix components that limit synapse formation (7), has resulted in sprouting of ascending and descending neural projections and improved motor function (7, 46, 89).”
BackgroundGlycans and glycosaminoglycans in neurobiology: key regulators of neuronal cell function and fate
Hayes, A. J., & Melrose, J. (2018) · Biochemical Journal · doi:10.1042/bcj20180283 · Cited by 61
Nakanishi, K., Aono, S., Hirano, K., Kuroda, Y., Ida, M., Tokita, Y., Matsui, F., & Oohira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601498200 · Cited by 58
Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system
Strappe, P., Hampton, D. W., Cachón-González, B., Fawcett, J. W., & Lever, A. M. L. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.06.006 · Cited by 59
Self-citationThe role of GABAergic inhibition in ocular dominance plasticity
Heimel, J. A., van Versendaal, D., & Levelt, C. N. (2011) · Neural Plasticity · doi:10.1155/2011/391763 · Cited by 57
“However, the interpretation of how the ECM limits adult cortical plasticity may have to be adjusted based on novel evidence [41].”
BackgroundDendritic spine dysgenesis contributes to hyperreflexia after spinal cord injury
Bandaru, S. P., Liu, S., Waxman, S. G., & Tan, A. M. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00566.2014 · Cited by 59
Sustaining intrinsic growth capacity of adult neurons promotes spinal cord regeneration
Neumann, S., Skinner, K., & Basbaum, A. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508538102 · Cited by 57
Okamoto, M., Sakiyama, J., Mori, S., Kurazono, S., Usui, S., Hasegawa, M., & Oohira, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00251-6 · Cited by 58
Zuidema, J. M., Provenza, C., Caliendo, T., Dutz, S., & Gilbert, R. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00189 · Cited by 60
The Role of Direct Current Electric Field-Guided Stem Cell Migration in Neural Regeneration
Yao, L., & Li, Y. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9654-8 · Cited by 57
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.